Seattle Alzheimer's Disease Brain Cell Atlas

The Seattle Alzheimer’s Disease Brain Cell Atlas (SEA-AD) consortium strives to gain a deep molecular and cellular understanding of the early pathogenesis of Alzheimer’s disease. To accomplish this, they are leveraging advances in next-generation single-cell molecular profiling technologies developed through the BRAIN Initiative and at the Allen Institute for Brain Science. They are integrating single-cell profiling technologies with quantitative neuropathology and deep clinical phenotyping through collaboration with the University of Washington Alzheimer's Disease Research Center (ADRC) and Kaiser Permanente Washington Health Research Institute (KPWHRI), to create a multifaceted open data resource. The SEA-AD consortium seeks to understand the cellular and molecular changes that underlie Alzheimer’s disease initiation and progressive cognitive decline, with the ultimate goal of identifying targets for therapeutic intervention.西雅图阿尔茨海默病脑细胞图谱联盟（Seattle Alzheimer’s Disease Brain Cell Atlas，SEA-AD）致力于深入解析阿尔茨海默病的早期发病分子与细胞机制。为达成这一目标，该联盟依托由美国脑计划（BRAIN Initiative）与艾伦脑科学研究所（Allen Institute for Brain Science）研发的新一代单细胞分子谱分析技术。该联盟正与华盛顿大学阿尔茨海默病研究中心（University of Washington Alzheimer's Disease Research Center，ADRC）及凯撒医疗机构华盛顿健康研究所（Kaiser Permanente Washington Health Research Institute，KPWHRI）展开合作，将单细胞谱分析技术与定量神经病理学、深度临床表型分型相结合，以构建多维度开放数据资源。SEA-AD联盟旨在阐明驱动阿尔茨海默病起始及进行性认知衰退的细胞与分子变化，最终目标是识别治疗干预靶点。

搜集汇总

背景与挑战

背景概述

西雅图阿尔茨海默病脑细胞图谱（SEA-AD）联盟致力于从分子和细胞层面深入理解阿尔茨海默病的早期发病机制。该联盟通过整合单细胞分析技术、定量神经病理学和深度临床表型数据，构建了一个多方面的开放数据资源，旨在揭示疾病起始和认知衰退背后的细胞与分子变化。